查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1553651

人工替代物市场规模、份额、趋势分析报告：按产品、按应用、按地区、细分市场预测，2024-2030

Bioprosthetics Market Size, Share & Trends Analysis Report By Product (Allograft, Xenograft), By Application (Cardiovascular, Plastic Surgery & Wound Healing), By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 80 Pages | 商品交期: 2-10个工作天内

价格
简介目录

人工替代物市场成长与趋势：

Grand View Research, Inc.最新报告显示，到2030年，全球人工替代物市场规模预计将达到76亿美元，2024年至2030年复合年增长率为4.4%。

与生活方式相关的习惯发生前所未有的转变，导致心血管疾病的高发病率，加上容易患心臟病和组织损伤的老龄化人口的增加，预计将在预测期内推动人工替代物市场的需求。

基于合成材料的义肢表现出较差的生物相容性、美观性和强度，这表明显然需要采用生物义肢。因此，对组织工程自体、同种异体和异种移植产品的需求不断增长，预计将为市场提供利润丰厚的成长机会。

该技术整合了球囊血管成形术和冠状动脉支架等各种设备，以及从心臟外科和介入性心臟病学等医学领域借鉴的广泛技术，为经导管瓣膜置换术带来了革命性的飞跃。此外，越来越多地采用超音波、血管造影术、MRI 和 CT 等非侵入性影像技术的组合，使外科医生能够监测设备和患者的解剖结构，从而无需进行心臟直视手术。

人工替代物市场报告亮点：

  • 预计同种异体移植市场在预测期内将以显着的复合年增长率成长。它可以缩短手术时间、缩小切口、提高生理可接受性、提供更大的移植物，并且是使用合成移植物进行手术的更安全的替代方案，因为合成移植物在麻醉下併发症的风险较高，因此具有以下相关优势，例如：
  • 预计整形外科和创伤治疗领域在预测期内的应用领域复合年增长率将超过 9.6%。这一巨大份额是由于软组织修復手术（例如疝气和腹壁重组）的增加。
  • 此外，根据 NCBI 发表的一项研究，病例的日益复杂性人工替代物了在执行上述手术时采用多学科方法的需求，以减少与慢性疾病相关的发病率。
  • 2023年，欧洲主导了整个人工替代物市场。此外，人口趋势的后续变化，例如频繁的产品核可、老年人群的增加、生活方式的变化以及与人工替代物解决方案的可用性相关的更高的意识层级，预计将推动该地区的市场成长。
  • 例如，2016 年 4 月，St. Jude Medical, Inc. 宣布在欧洲推出 Trifecta 手术瓣膜，为需要主动脉置换术的患者提供增强的选择。此次发布扩大了 St. Jude Medical 在欧洲的现有产品系列。
  • 该行业的一些主要公司包括 Edwards Lifesciences Corporation、St.Jude Medical, Inc.、Sorin Group、CryoLife, Inc.、Braile Biomedica, Inc. 和 Medtronic Plc，预计将推动其业务扩张。并更频繁地获得产品认证。

目录

第一章调查方法与范围

第 2 章执行摘要

第三章人工替代物市场变数、趋势与范围

  • 市场介绍/系统展望
  • 市场规模及成长前景
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
  • 人工替代物市场分析工具
    • 波特的分析
    • PESTEL分析

第 4 章人工替代物市场：依产品分类的估算与趋势分析

  • 细分仪表板
  • 人工替代物市场：2023 年和 2030 年产品变化分析
  • 同种异体移植
  • 异种移植

第五章人工替代物市场：按应用估算与趋势分析

  • 细分仪表板
  • 人工替代物市场：2023 年和 2030 年应用变化分析
  • 心血管
  • 整形外科和创伤治疗

第六章人工替代物市场：区域估计与趋势分析

  • 2023 年及 2030 年人工替代物市场占有率（按地区）
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 丹麦
    • 瑞典
    • 挪威
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 韩国
    • 泰国
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中东和非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第七章 竞争格局

  • 主要市场参与企业的最新趋势和影响分析
  • 公司分类
  • 企业热力图分析
  • 公司简介
    • LeMaitre Vascular, Inc.
    • Braile Biomedica
    • Labcor Laboratorios Ltda
    • Medtronic
    • Rua Life Sciences Plc（Aortech International Plc.）
    • LivaNova PLC（Sorin Group）
    • Organogenesis Inc.
    • Humacyte Global, Inc.
    • Johnson &Johnson（Ethicon, Inc.）
    • Artivion, Inc.（CryoLife, Inc.）
    • Abbott（St. Jude Medical, Inc.）
    • Edwards Lifesciences Corporation.
    • JenaValve
简介目录
Product Code: 978-1-68038-980-7

Bioprosthetics Market Growth & Trends:

The global bioprosthetics market size is expected to reach USD 7.6 billion by 2030, registering to grow at a CAGR of 4.4% from 2024 to 2030 according to a new report by Grand View Research, Inc. The unprecedented upward shift in the lifestyle-associated habits leading to the high prevalence of cardiovascular diseases coupled with the increasing geriatric population base,which is highly susceptible to developing cardiac impairments and tissue damage,are presumed to impel the demand for the bioprosthetics market during the forecast period.

Lower biocompatibility, aesthetics, and strength exhibited by the synthetic material-based prosthetics indicate the indisputable requirement for incorporating bioprosthetics; consequentially, the increasing need for the tissue-engineered autologous, allogenic or xenograft products is anticipated to present the market with lucrative growth opportunities.

The growth in the demand for bioprostheses is attributed mainly to technological advancements comprising trans catheter valve fabrication technology, the construction of which involves a multidisciplinary approach, wherein wide-ranging technologies borrowed from varied devices including balloon angioplasty and coronary stents as well as medical disciplines, such as cardiac surgery and interventional cardiology, are merged to introduce a revolutionary quantum leap in the transcatheter valve replacement procedures. Moreover, a combination of the non-invasive imaging techniques, such as, echo cardiography angiography, MRI, and CT, are increasingly being employed, which allows the surgeons to visualize both the device and the anatomy of the patient thus eliminating the need to conduct an open heart surgery.

Bioprosthetics Market Report Highlights:

  • The allograft segment is expected to exhibit growth at a significant CAGR during the forecast period. This is a consequence of the following associated advantages such as reduced surgical time, smaller incisions, greater physiological acceptability, availability of larger grafts, and a safer alternative to procedures that employ synthetic grafts as they pose a high risk of complications under anesthesia
  • The plastic surgery and wound healing segment is anticipated to witness an exponential CAGR of over 9.6% in the application segment over the forecast period. This substantial share can be attributed to the increasing number of soft tissue repair procedures, such as in hernia and abdominal wall reconstruction
  • Additionally, as per a research published by the NCBI, the increase in case complexities drive the need to apply a multidisciplinary approach in performing the above-mentioned procedures, which augments the use of these bioprosthetics meshes to decrease the morbidity associated with chronic impairments
  • In 2023, Europe dominated the overall bioprosthetics market. Moreover, the subsequent changes in the demographic trends, such as the frequent product approvals, increasing geriatric population base, lifestyle-associated changes, and the high awareness levels pertaining to the availability of bioprosthetics solutions are anticipated to drive the market growth in this region
  • For instance, In April 2016, St. Jude Medical, Inc. announced the European launch of Trifecta Surgical Valve to provide enhanced alternatives to patients requiring aortic valve replacements. This launch resulted in the expansion of the existing product portfolio of St. Jude Medical, Inc. in Europe
  • Some leading players in this industry include Edwards Lifesciences Corporation, St.Jude Medical, Inc., Sorin Group, CryoLife, Inc., Braile Biomedica, Inc., and Medtronic Plc; these players are increasingly involved in adopting collaborative strategies and launching frequent product approvals to facilitate business expansion

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
  • 1.3. Research Methodology
    • 1.3.1. Information Procurement
    • 1.3.2. Information or Data Analysis
    • 1.3.3. Market Formulation & Data Visualization
    • 1.3.4. Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1. List of Data Sources

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Bioprosthetics Market Variables, Trends, & Scope

  • 3.1. Market Introduction/Lineage Outlook
  • 3.2. Market Size and Growth Prospects (USD Million)
  • 3.3. Market Dynamics
    • 3.3.1. Market Drivers Analysis
    • 3.3.2. Market Restraints Analysis
  • 3.4. Bioprosthetics Market Analysis Tools
    • 3.4.1. Porter's Analysis
      • 3.4.1.1. Bargaining power of the suppliers
      • 3.4.1.2. Bargaining power of the buyers
      • 3.4.1.3. Threats of substitution
      • 3.4.1.4. Threats from new entrants
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Economic and Social landscape
      • 3.4.2.3. Technological landscape
      • 3.4.2.4. Environmental landscape
      • 3.4.2.5. Legal landscape

Chapter 4. Bioprosthetics Market: Product Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Bioprosthetics Market: Product Movement Analysis, 2023 & 2030 (USD Million)
  • 4.3. Allograft
    • 4.3.1. Allograft Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.4. Xenograft
    • 4.4.1. Xenograft Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.4.2. Porcine
      • 4.4.2.1. Porcine Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.4.3. Bovine
      • 4.4.3.1. Bovine Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Bioprosthetics Market: Application Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Bioprosthetics Market: Application Movement Analysis, 2023 & 2030 (USD Million)
  • 5.3. Cardiovascular
    • 5.3.1. Cardiovascular Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.4. Plastic Surgery & Wound Healing
    • 5.4.1. Plastic Surgery & Wound Healing Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million

Chapter 6. Bioprosthetics Market: Regional Estimates & Trend Analysis

  • 6.1. Bioprosthetics Market Share, By Region, 2023 & 2030 (USD Million)
  • 6.2. North America
    • 6.2.1. North America Bioprosthetics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.2.2. U.S.
      • 6.2.2.1. U.S. Bioprosthetics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.2.3. Canada
      • 6.2.3.1. Canada Bioprosthetics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.2.4. Mexico
      • 6.2.4.1. Mexico Bioprosthetics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.3. Europe
    • 6.3.1. Europe Bioprosthetics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.2. U.K.
      • 6.3.2.1. U.K. Bioprosthetics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.3. Germany
      • 6.3.3.1. Germany Bioprosthetics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.4. France
      • 6.3.4.1. France Bioprosthetics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.5. Italy
      • 6.3.5.1. Italy Bioprosthetics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.6. Spain
      • 6.3.6.1. Spain Bioprosthetics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.7. Denmark
      • 6.3.7.1. Denmark Bioprosthetics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.8. Sweden
      • 6.3.8.1. Spain Bioprosthetics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.9. Norway
      • 6.3.9.1. Norway Bioprosthetics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.4. Asia Pacific
    • 6.4.1. Asia Pacific Bioprosthetics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.2. Japan
      • 6.4.2.1. Japan Bioprosthetics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.3. China
      • 6.4.3.1. China Bioprosthetics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.4. India
      • 6.4.4.1. India Bioprosthetics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.5. Australia
      • 6.4.5.1. Australia Bioprosthetics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.6. South Korea
      • 6.4.6.1. South Korea Bioprosthetics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.7. Thailand
      • 6.4.7.1. Thailand Korea Bioprosthetics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5. Latin America
    • 6.5.1. Latin America Bioprosthetics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.2. Brazil
      • 6.5.2.1. Brazil Bioprosthetics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.3. Argentina
      • 6.5.3.1. Argentina Bioprosthetics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6. Middle East and Africa
    • 6.6.1. Middle East and Africa Bioprosthetics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.2. South Africa
      • 6.6.2.1. South Africa Bioprosthetics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.3. Saudi Arabia
      • 6.6.3.1. Saudi Arabia Bioprosthetics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.4. UAE
      • 6.6.4.1. UAE Bioprosthetics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.5. Kuwait
      • 6.6.5.1. Kuwait Bioprosthetics Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis by Key Market Participants
  • 7.2. Company Categorization
  • 7.3. Company Heat Map Analysis
  • 7.4. Company Profiles
    • 7.4.1. LeMaitre Vascular, Inc.
      • 7.4.1.1. Participant's Overview
      • 7.4.1.2. Financial Performance
      • 7.4.1.3. Product Benchmarking
      • 7.4.1.4. Recent Developments/ Strategic Initiatives
    • 7.4.2. Braile Biomedica
      • 7.4.2.1. Participant's Overview
      • 7.4.2.2. Financial Performance
      • 7.4.2.3. Product Benchmarking
      • 7.4.2.4. Recent Developments/ Strategic Initiatives
    • 7.4.3. Labcor Laboratorios Ltda
      • 7.4.3.1. Participant's Overview
      • 7.4.3.2. Financial Performance
      • 7.4.3.3. Product Benchmarking
      • 7.4.3.4. Recent Developments/ Strategic Initiatives
    • 7.4.4. Medtronic
      • 7.4.4.1. Participant's Overview
      • 7.4.4.2. Financial Performance
      • 7.4.4.3. Product Benchmarking
      • 7.4.4.4. Recent Developments/ Strategic Initiatives
    • 7.4.5. Rua Life Sciences Plc (Aortech International Plc.)
      • 7.4.5.1. Participant's Overview
      • 7.4.5.2. Financial Performance
      • 7.4.5.3. Product Benchmarking
      • 7.4.5.4. Recent Developments/ Strategic Initiatives
    • 7.4.6. LivaNova PLC (Sorin Group)
      • 7.4.6.1. Participant's Overview
      • 7.4.6.2. Financial Performance
      • 7.4.6.3. Product Benchmarking
      • 7.4.6.4. Recent Developments/ Strategic Initiatives
    • 7.4.7. Organogenesis Inc.
      • 7.4.7.1. Participant's Overview
      • 7.4.7.2. Financial Performance
      • 7.4.7.3. Product Benchmarking
      • 7.4.7.4. Recent Developments/ Strategic Initiatives
    • 7.4.8. Humacyte Global, Inc.
      • 7.4.8.1. Participant's Overview
      • 7.4.8.2. Financial Performance
      • 7.4.8.3. Product Benchmarking
      • 7.4.8.4. Recent Developments/ Strategic Initiatives
    • 7.4.9. Johnson & Johnson (Ethicon, Inc.)
      • 7.4.9.1. Participant's Overview
      • 7.4.9.2. Financial Performance
      • 7.4.9.3. Product Benchmarking
      • 7.4.9.4. Recent Developments/ Strategic Initiatives
    • 7.4.10. Artivion, Inc. (CryoLife, Inc.)
      • 7.4.10.1. Participant's Overview
      • 7.4.10.2. Financial Performance
      • 7.4.10.3. Product Benchmarking
      • 7.4.10.4. Recent Developments/ Strategic Initiatives
    • 7.4.11. Abbott (St. Jude Medical, Inc.)
      • 7.4.11.1. Participant's Overview
      • 7.4.11.2. Financial Performance
      • 7.4.11.3. Product Benchmarking
      • 7.4.11.4. Recent Developments/ Strategic Initiatives
    • 7.4.12. Edwards Lifesciences Corporation.
      • 7.4.12.1. Participant's Overview
      • 7.4.12.2. Financial Performance
      • 7.4.12.3. Product Benchmarking
      • 7.4.12.4. Recent Developments/ Strategic Initiatives
    • 7.4.13. JenaValve
      • 7.4.13.1. Participant's Overview
      • 7.4.13.2. Financial Performance
      • 7.4.13.3. Product Benchmarking
      • 7.4.13.4. Recent Developments/ Strategic Initiatives